Startup session

Спикеры Клуба

Sharareh Salar-Behzadi

Research Center Pharmaceutical Engineering GmbH Principal Researcher

Dr. Mike Brownleader

Director of European Operations and Sales for CalibreScientific

Dr. Teodor Aastrup

CEO of Attana, PhD.

Рудольф Валента

Заведующий отделением иммунопатологии, отдел патофизиологии и исследований аллергии, Венский медицинский университет, Австрия

Муса Хаитов

Директор ФГБУ «ГНЦ Институт иммунологии» ФМБА России

Райнер Хеннинг

PhD, Chief Executive Officer, Biomay

ПУБЛИКАЦИИ ПАРТНЕРОВ

П У Б Л И К А Ц И И

Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein

In the present study targeting of human cancer cells with a glycosaminoglycan binding malaria protein (VAR2CSA) was investigated. The present work utilises Attana QCM technology to perform binding studies using both cell based and biochemical approaches.

EUROSTARS: CellSenseGels

Participants - University Of Stuttgart, Biogelx Ltd, Attana AB.

Immunoassays to maximize productivity in bioprocess development

Gyrolab systems meet the needs of many biopharmaceutical companies that apply immunoassays to bioanalysis throughout bioprocess development. Gyrolab immunoassay platform addresses bottlenecks and delays by providing rapid assay development time, automation, high throughput, and a broad dynamic range that minimizes dilutions and repeats.

Research on Gyrolab® platform at nanoliter-scale reduces sample requirements and animal use.

г. Москва, Трубецкая ул., д. 8